Related Experiment Videos
Depression, medication adherence, and service utilization in systemic lupus erythematosus
Laura J Julian1, Edward Yelin, Jinoos Yazdany
1University of California, San Francisco, CA 94143-0920, USA. laura.julian@ucsf.edu
Arthritis and Rheumatism
|January 30, 2009
Summary
Depression significantly impacts medication adherence in systemic lupus erythematosus (SLE) patients. Addressing adherence issues can reduce healthcare costs and improve outcomes for SLE individuals.
Area of Science:
- Rheumatology
- Psychiatry
- Health Services Research
Background:
- Medication nonadherence is a significant challenge in managing chronic conditions like systemic lupus erythematosus (SLE).
- Forgetting to take medications is a common reason for nonadherence, impacting treatment efficacy and patient outcomes.
- Understanding factors contributing to forgetting medications is crucial for developing targeted interventions.
Purpose of the Study:
- To identify factors associated with forgetting to take medications in a large cohort of SLE patients.
- To examine the relationship between medication adherence problems and healthcare service utilization patterns.
Main Methods:
- The study analyzed data from 834 participants in the University of California, San Francisco Lupus Outcomes Study (LOS).
- Self-reported frequency of forgetting medications was assessed alongside sociodemographic, disease-related, and mental health characteristics (including depression and cognitive function).
- Healthcare utilization, including outpatient visits, emergency department visits, and hospitalizations, was recorded.
Main Results:
- Nearly half (46%) of SLE patients reported forgetting medications at least occasionally.
- Higher depressive symptom severity was a strong predictor of adherence difficulties (OR 1.04, P < 0.0001).
- Patients with adherence difficulties had more outpatient visits and higher likelihood of emergency department visits (OR 1.45, P = 0.03).
Conclusions:
- Depression is a key factor contributing to medication adherence problems in SLE patients.
- Adherence difficulties are linked to increased healthcare utilization, particularly costly emergency department visits.
- Identifying at-risk patients for adherence issues can potentially reduce medical expenditures and enhance patient outcomes in SLE management.
Related Concept Videos
Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
Nephrotic Syndrome II : Assessment and Medical Management
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document any history...
Nephrotic Syndrome III : Nursing Management
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
Therapeutic Drug Monitoring: Affecting Factors
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
Psychosis: Goals of Pharmacotherapy
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation. For...